🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

2,762 results for “CTI” Clear

  1. Vancomycin

    The First People's Hospital of Lianyungang

    Blood Stream Infections

    approved small molecule active

    1 trial

  2. Vardenafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Erectile Dysfunction

    approved small molecule active

    1 trial

  3. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geïnactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial

  4. Vedolizumab

    Takeda

    Moderately to Severely Active Crohn's Disease

    approved mab active

    1 trial

  5. Video directly observed therapy with contingency management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other active

    1 trial

  6. Vonoprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    2 trials

  7. Vonoprazan and Amoxicillin for the first 7 days

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    1 trial

  8. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  9. WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL

    Fondazione Telethon ETS

    Myocardial infarction with non-obstructive coronary arteries (MINOCA)

    approved small molecule active

    1 trial

  10. Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen

    NovoThirteen

    Obesity

    approved small molecule active

    1 trial

  11. Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen

    Lacuna Pharma Pty Ltd

    Adipositas

    approved small molecule active

    1 trial

  12. Wegovy 2.4 mg solution for injection in pre-filled pen

    The George Institute

    obstructive sleep apnea

    approved small molecule active

    1 trial

  13. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial

  14. Xiang Sha Liu Jun Zi Decoction dry powder

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule completed

    1 trial

  15. Xingnaojing injection

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    1 trial

  16. Xingnaojing injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  17. Xingnaojing injection

    Universal Integrated

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  18. Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets

    Bayer AG

    metastatic castrate resistant prostate cancer (mCRPC)

    approved small molecule active

    1 trial

  19. Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  20. Xolair 75 mg solution for injection in pre-filled syringe

    Pari Pharma GmbH

    Well controlled severe allergic asthma

    approved small molecule active

    1 trial

  21. Xuebijing

    Rocket Pharmaceuticals B.V.

    Pulmonary Disease, Chronic Obstructive

    approved small molecule active

    1 trial

  22. Xuebijing Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule completed

    2 trials

  23. Xyrem (X)

    Jazz Pharmaceuticals Ireland Limited

    Obstructive Sleep Apnea Syndrome

    approved small molecule completed

    1 trial

  24. Yuflyma 40 mg solution for injection in pre-filled pen, Hyrimoz 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled pen, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled s

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources